Eric Olson

Array ( [id] => 7305978 [patent_doc_number] => 20040116379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Therapy-enhancing glucan' [patent_app_type] => new [patent_app_number] => 10/621027 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24065 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116379.pdf [firstpage_image] =>[orig_patent_app_number] => 10621027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314696 [patent_doc_number] => 20040034086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Combination of an allosteric inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib' [patent_app_type] => new [patent_app_number] => 10/620174 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51491 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034086.pdf [firstpage_image] =>[orig_patent_app_number] => 10620174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404254 [patent_doc_number] => 20040023969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib' [patent_app_type] => new [patent_app_number] => 10/619777 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023969.pdf [firstpage_image] =>[orig_patent_app_number] => 10619777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401621 [patent_doc_number] => 20040019053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib' [patent_app_type] => new [patent_app_number] => 10/619662 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75012 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019053.pdf [firstpage_image] =>[orig_patent_app_number] => 10619662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694782 [patent_doc_number] => 20060154929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds' [patent_app_type] => utility [patent_app_number] => 10/520962 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34766 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154929.pdf [firstpage_image] =>[orig_patent_app_number] => 10520962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270432 [patent_doc_number] => 20040058950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors' [patent_app_type] => new [patent_app_number] => 10/614365 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9055 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058950.pdf [firstpage_image] =>[orig_patent_app_number] => 10614365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367523 [patent_doc_number] => 20040006053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method of long-term treatment of Graft-Versus-Host Disease using topical active corticosteriods' [patent_app_type] => new [patent_app_number] => 10/613788 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2338 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006053.pdf [firstpage_image] =>[orig_patent_app_number] => 10613788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404716 [patent_doc_number] => 20040024007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors' [patent_app_type] => new [patent_app_number] => 10/613783 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9939 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024007.pdf [firstpage_image] =>[orig_patent_app_number] => 10613783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468184 [patent_doc_number] => 20040053918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Erythropoietin production potentiator' [patent_app_type] => new [patent_app_number] => 10/607996 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053918.pdf [firstpage_image] =>[orig_patent_app_number] => 10607996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207597 [patent_doc_number] => 20040087608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Pharmaceuticals for neuropathic pain' [patent_app_type] => new [patent_app_number] => 10/603936 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4723 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087608.pdf [firstpage_image] =>[orig_patent_app_number] => 10603936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473913 [patent_doc_number] => 20040097405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Method of treating cartilage damage' [patent_app_type] => new [patent_app_number] => 10/602413 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61657 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097405.pdf [firstpage_image] =>[orig_patent_app_number] => 10602413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306478 [patent_doc_number] => 20040116506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Use of levetiracetam for treating or preventing acute headaches' [patent_app_type] => new [patent_app_number] => 10/600818 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116506.pdf [firstpage_image] =>[orig_patent_app_number] => 10600818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535363 [patent_doc_number] => 07176189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Methods for regeneration of a mammalian lens' [patent_app_type] => utility [patent_app_number] => 10/600745 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14517 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176189.pdf [firstpage_image] =>[orig_patent_app_number] => 10600745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097322 [patent_doc_number] => 20050129780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Relief of aids symptoms' [patent_app_type] => utility [patent_app_number] => 10/515773 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6477 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129780.pdf [firstpage_image] =>[orig_patent_app_number] => 10515773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851789 [patent_doc_number] => 20060234980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food' [patent_app_type] => utility [patent_app_number] => 10/516234 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5230 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234980.pdf [firstpage_image] =>[orig_patent_app_number] => 10516234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583776 [patent_doc_number] => 07851450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Gangliosides with a modified acyl function' [patent_app_type] => utility [patent_app_number] => 10/497173 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851450.pdf [firstpage_image] =>[orig_patent_app_number] => 10497173 [rel_patent_id] =>[rel_patent_doc_number] =>)